Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/07/2026: OFIX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.8
1 Year Target Price $22.8
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.98% | Avg. Invested days 27 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/07/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 622.90M USD | Price to earnings Ratio - | 1Y Target Price 22.8 |
Price to earnings Ratio - | 1Y Target Price 22.8 | ||
Volume (30-day avg) 5 | Beta 0.79 | 52 Weeks Range 10.24 - 20.48 | Updated Date 01/7/2026 |
52 Weeks Range 10.24 - 20.48 | Updated Date 01/7/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.56% | Operating Margin (TTM) -8.35% |
Management Effectiveness
Return on Assets (TTM) -5.46% | Return on Equity (TTM) -24.6% |
Valuation
Trailing PE - | Forward PE 31.55 | Enterprise Value 764524636 | Price to Sales(TTM) 0.76 |
Enterprise Value 764524636 | Price to Sales(TTM) 0.76 | ||
Enterprise Value to Revenue 0.93 | Enterprise Value to EBITDA 145.24 | Shares Outstanding 39599659 | Shares Floating 39113771 |
Shares Outstanding 39599659 | Shares Floating 39113771 | ||
Percent Insiders 2.4 | Percent Institutions 91.3 |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980 in Verona, Italy, by Dr. Giovanni De Bastiani. It initially focused on developing and manufacturing external fixation devices for limb lengthening and reconstruction. Over the decades, Orthofix expanded its product portfolio and global reach, becoming a significant player in the orthopedic and spine industry. Key milestones include its IPO on the NASDAQ stock exchange in 1990 and strategic acquisitions that broadened its surgical solutions.
Core Business Areas
- Extremity Fixation: Designs, manufactures, and markets innovative orthopedic devices for the treatment of complex limb deformities, trauma, and conditions affecting the extremities, including the arms, legs, and pelvis. These devices often involve external frames and internal implants.
- Spinal Implants: Offers a comprehensive range of surgical solutions for spinal pathologies, including cervical, thoracic, and lumbar spine disorders. This segment includes implants, instrumentation, and biologics designed to facilitate spinal fusion and stabilization.
- Biologics: Provides bone graft substitutes and other biological materials that aid in bone healing and fusion, complementing their implant and fixation systems across various orthopedic procedures.
Leadership and Structure
Orthofix Medical Inc. is led by a senior management team responsible for its global operations. The organizational structure is typically divided by business segments and geographic regions, with a focus on research and development, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- FITBONE Nailing System: A motorized intramedullary nail designed for limb lengthening and correction of deformities. It allows for controlled lengthening and gradual correction through an external remote control. Competitors include established players in the limb reconstruction market like Smith & Nephew, Zimmer Biomet, and Stryker.
- Axial LIF System: A comprehensive anterior lumbar interbody fusion system that offers multiple cage options and fixation techniques for the treatment of degenerative disc disease and other lumbar spine conditions. Competitors include Medtronic, NuVasive, and DePuy Synthes.
- LAGUNA Titanium PLIF System: A posterior lumbar interbody fusion system designed to provide stability and facilitate fusion in the lumbar spine. Key competitors are similar to the Axial LIF system, including major spine implant manufacturers.
Market Dynamics
Industry Overview
Orthofix operates within the global orthopedic and spine market, a highly competitive and dynamic industry driven by an aging population, increasing prevalence of orthopedic conditions, advancements in surgical technologies, and a growing demand for minimally invasive procedures. The market is characterized by innovation, consolidation, and a focus on patient outcomes.
Positioning
Orthofix is positioned as a specialized provider of orthopedic and spine solutions, focusing on niche areas like limb lengthening and complex spine procedures. Its competitive advantages lie in its innovative product development, particularly in external fixation technologies, and its expanding global commercial infrastructure.
Total Addressable Market (TAM)
The global orthopedic devices market is valued in the tens of billions of dollars, with the spine segment being a significant portion. Orthofix's TAM is therefore substantial, and it is positioned to capture a growing share through its focused product offerings and strategic initiatives, though it is a smaller player compared to industry giants.
Upturn SWOT Analysis
Strengths
- Proprietary technologies in limb lengthening and deformity correction.
- Established global distribution network.
- Strong reputation for innovation in specific orthopedic niches.
- Diversified product portfolio across spine and extremities.
- Experienced management team.
Weaknesses
- Smaller market share compared to larger, diversified medical device companies.
- Dependence on key product lines.
- Potential for challenges in integrating acquired businesses.
- Brand recognition may be lower in certain broad orthopedic segments.
Opportunities
- Expansion into emerging markets.
- Development of new biologics and regenerative medicine solutions.
- Strategic acquisitions to broaden product offerings and market reach.
- Increasing demand for minimally invasive spine procedures.
- Leveraging data analytics and digital health solutions.
Threats
- Intense competition from larger medical device manufacturers.
- Regulatory hurdles and changes in healthcare policies.
- Pricing pressures from payers and healthcare systems.
- Potential for product recalls or adverse events.
- Economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- Medtronic plc (MDT)
- Stryker Corporation (SYK)
- Zimmer Biomet Holdings, Inc. (ZBH)
- DePuy Synthes (a Johnson & Johnson company)
- NuVasive, Inc. (NUVA)
Competitive Landscape
Orthofix faces strong competition from much larger, diversified medical device companies. Its advantages lie in its specialized focus and innovative technologies within its niche segments. However, it must compete on product efficacy, cost-effectiveness, and physician relationships against giants with broader portfolios and larger R&D budgets.
Major Acquisitions
SeaSpine Holdings Corporation
- Year: 2023
- Acquisition Price (USD millions): 400
- Strategic Rationale: To significantly enhance Orthofix's position in the spine market by combining complementary product portfolios and creating a more comprehensive spine solutions offering, leading to cost synergies and revenue growth opportunities.
Innovasis
- Year: 2011
- Acquisition Price (USD millions): 120
- Strategic Rationale: To expand Orthofix's spinal implant portfolio and strengthen its presence in the U.S. spine market.
Growth Trajectory and Initiatives
Historical Growth: Orthofix has shown a growth trajectory driven by organic product development and strategic acquisitions. The company has expanded its product portfolio and geographic presence over time. The acquisition of SeaSpine in 2023 was a significant event, aiming to create a more robust spine business.
Future Projections: Future growth is projected to be driven by the integration of SeaSpine, continued innovation in its core segments, expansion into new markets, and potential further strategic acquisitions. Analyst projections will typically focus on revenue growth, EPS accretion, and market penetration.
Recent Initiatives: Key recent initiatives include the significant acquisition of SeaSpine, aimed at creating a leading spine solutions company, and continued investment in research and development for its extremity fixation and biologics segments.
Summary
Orthofix Medical Inc. is a specialized orthopedic and spine company with strengths in limb reconstruction and emerging strength in spine following the SeaSpine acquisition. Its focus on innovation and niche markets provides a competitive edge. However, it faces significant competition from larger players. Careful integration of recent acquisitions and continued R&D investment are critical for sustained growth and market position.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Orthofix Medical Inc. Investor Relations.
- SEC Filings (10-K, 10-Q).
- Industry Analysis Reports.
- Financial News Outlets.
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Market share data and financial metrics are estimates and may vary based on reporting periods and methodologies. Historical performance is not indicative of future results. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO & Director Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.